Speaker illustration

Doctor Robert Zilberszac

Medical University of Vienna, Vienna (Austria)

Dr. Zilberszac, born 1985, went to Medical School from 2005-2011 at the Medical University of Vienna, Austria. During that period, he started to work as a research assistant in the Heart Valve Clinic (under Prof. Raphael Rosenhek) of the University's Department of Cardiology. He was awarded multiple performance scholarships and spent 2 semesters as an "ERASMUS" scholar at the Charité University Hospital in Berlin, Germany. Dr Zilberszac started his clinical training at the German Heart Centre Munich, before he joined the Department of Cardiology of the Medical University of Vienna as a resident in 2012. During his ongoing clinical training, he graduated from the University's Doctoral Programme of Applied Medical Science in 2017 and spent one year as a guest researcher and registrar at the Royal Adelaide Hospital in Australia. Currenly, Dr. Zilberszac works as a Cardiology fellow at the Medical University of Vienna with his research interest focussed on valvular heart disease.

Left atrial size is a powerful predictor of outcome in severe asymptomatic primary mitral regurgitation

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Best Posters in mitral regurgitation


Long term outcome of watchful waiting in severe but asymptomatic primary mitral regurgitation

Event: ESC Congress 2017

Topic: Mitral valve disease

Session: Assessment, treatment and prognosis of complex mitral disease


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb